According
to a new market report published by Transparency Market Research
"Transcriptomics Technologies Market (Microarrays, PCR, Gene
Regulation and Next Generation Sequencing) - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"
the global transcriptomics technologies market was valued at USD 1.65
billion in 2012 and is expected to grow at a CAGR of 15.9% from 2013
to 2019, to reach an estimated value of USD 4.6 billion in 2019.
Browse
the full report with Complete TOC at
http://www.transparencymarketresearch.com/transcriptomics-technologies-market.html
Transcriptome
refers to the complete set of all coding and non-coding ribonucleic
acid (RNA) molecules present in an individual or population of cells.
Transcriptome accounts for about less than 5% of the total genome.
Transcriptomics research refers to the study of functional and
structural aspects of RNA transcripts in a given cell. This research
provides insights about the gene expression and gene regulation
mechanisms in normal and diseased cells such as cancerous cells. In
addition it aids in identification of novel gene sequences and
potential drug targets. With the increasing preference for
personalized medicine and companion diagnostics, transcriptome
technologies promises increased participation of pharmaceutical and
biotechnology companies in healthcare and medical research projects.
The most important factors favoring growth of global transcriptomics
market include consistent technological upgradation followed by
increased healthcare and R&D expenditure by pharmaceutical and
biotechnology companies. Also, continuous exploration of biomarkers
and novel gene sequences will drive the growth and acceptance of
transcriptomics technologies across the globe.
Lack
of effective bioinformatics tools employed for transcriptome analysis
is one of the major factors expected to hamper the ready acceptance
of transcriptome analysis tools and services. In addition, lack of
awareness about genomic medicine and domain expertise are the other
factors which might restrain the market growth. Increased research
investments made by several pharmaceutical and biotechnology
companies to develop targeted therapeutics, provide a growth
opportunity to the transcriptomics technologies. Currently, the trend
of contract research outsourcing is advantageous for the development
and commercialization of transcriptomics research outcomes.
The
global transcriptomics technologies market can be categorized by
technology, application and geography. RNA sequencing technologies
have surpassed the usage of microarrays in drug discovery and
research with increased efficiency and reliability. Transcriptomics
technologies market for microarrays was the most prominent segment of
the market in 2012 by revenue. However, next generation sequencing
technologies are steadily surpassing the use of microarrays, owing to
their higher efficiency, reliability and capabilities. Extensive
research activities and technological evolution of sequencing
platforms further propel adoption of next generation sequencing
technologies. Another attractive segment of this market is that of
gene regulation technologies such as micro RNA and RNA interference
technology. These technologies regulate proper functioning of the
genes in normal as well as diseased cells. It is estimated that the
market for gene regulation technologies will grow at a CAGR of over
15% from 2013 to 2019.
At
the regional level, North America was the largest market in 2012 for
transcriptomics technologies followed by the European region.
Presence of sophisticated and well infrastructured research and
medical laboratories followed by increased participation of
respective governments in healthcare sector will propel growth and
acceptance of transcriptomics research in North American market. The
Asia-Pacific region is expected to record commendable growth by 2019
due to huge untapped potential population, rising disposable income,
increased healthcare investments and extensive research carried out
in the biotechnology field.
Transcriptomics
technologies market is characterized by the presence of established
players as well as new players solely operating in this market. The
major companies competing in this market are Agilent Technologies,
Inc., Affymetrix, Inc., Life Technologies Corporation, Illumina,
Inc., F-Hoffmann La Roche Ltd. and Thermo Fisher Scientific.
Related
Published Reports by Transparency Market Research
Atrial Fibrillation Market: http://www.transparencymarketresearch.com/atrial-fibrillation-market.html
Freeze
Drying Equipment Market:
http://www.transparencymarketresearch.com/freeze-drying-equipment-market.html
Metal
Cans Market:
http://www.transparencymarketresearch.com/metal-cans-market.html
The
global transcriptomics technologies market is segmented as follows:
Transcriptomics Technologies Market, by Technology
Microarrays
Polymerase
Chain Reaction (PCR)
Gene
Regulation Technologies (mRNA and RNAi technology)
Next
Generation Sequencing (NGS) technologies
Request
a Sample of this Report
:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1659
Transcriptomics
Technologies Market, by Application
Clinical Diagnostics
Drug
Discovery and Research
Bioinformatics
Comparative
Transcriptome studies
Transcriptomics Technologies Market, by Geography
North America
Europe
Asia-Pacific
Rest
of the World (RoW)
Browse
all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.

The transcriptomics group is a necessary link between the genetic information of the genome and the biological function (proteome). Compared with the whole genome sequencing, the sequence of the genome sequence was not containing the intron and other non encoding sequences. So the sequencing of the transcription has an unparalleled high cost advantage.
ReplyDelete